简体中文|English
Trial search Nation, Province(City) Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Recruiting status Register status Measure Ethical committee Study type
Measure statistics in Global
Year：

None

Check the details 35921(14.04%)

Nil

Check the details 5888(2.30%)

NA

Check the details 5312(2.08%)

Not filled

Check the details 4953(1.94%)

No

Check the details 4479(1.75%)

N/A

Check the details 4358(1.70%)

Placebo

Check the details 1538(0.60%)

no intervention

Check the details 1403(0.55%)

Check the details 648(0.25%)

acupuncture

Check the details 467(0.18%)

usual care

Check the details 406(0.16%)

routine care

Check the details 378(0.15%)

Normal saline

Check the details 346(0.14%)

Health education

Check the details 300(0.12%)

propofol

Check the details 297(0.12%)

Conventional treatment

Check the details 294(0.11%)

Not applicable

Check the details 257(0.10%)

nothing

Check the details 254(0.10%)

Conventional therapy

Check the details 253(0.10%)

Dexmedetomidine

Check the details 231(0.09%)

Null

Check the details 230(0.09%)

SURGERY

Check the details 213(0.08%)

Sham stimulation

Check the details 209(0.08%)

general anesthesia

Check the details 205(0.08%)

Routine treatment

Check the details 195(0.08%)

Non

Check the details 178(0.07%)

Sham acupuncture

Check the details 167(0.07%)

chemotherapy

Check the details 157(0.06%)

Basic treatment

Check the details 149(0.06%)

Blank control

Check the details 145(0.06%)

None

Check the details 143(0.06%)

saline

Check the details 140(0.05%)

Electroacupuncture

Check the details 138(0.05%)

conventional treatment

Check the details 133(0.05%)

standard treatment

Check the details 118(0.05%)

Esketamine

Check the details 111(0.04%)

Blank

Check the details 107(0.04%)

Routine nursing

Check the details 105(0.04%)

non-intervention

Check the details 105(0.04%)

rTMS

Check the details 103(0.04%)

Sufentanil

Check the details 97(0.04%)

observation

Check the details 93(0.04%)

Control

Check the details 93(0.04%)

Medication

Check the details 90(0.04%)

Remimazolam

Check the details 89(0.03%)

metformin

Check the details 87(0.03%)

Probiotics

Check the details 87(0.03%)

Oral placebo

Check the details 86(0.03%)

aerobic exercise

Check the details 81(0.03%)

Radiotherapy

Check the details 79(0.03%)

None.

Check the details 77(0.03%)

no treatment

Check the details 69(0.03%)

Western medicine

Check the details 67(0.03%)

Apatinib

Check the details 67(0.03%)

no interventions

Check the details 66(0.03%)

Sevoflurane

Check the details 66(0.03%)

Routine health education

Check the details 64(0.03%)

Ropivacaine

Check the details 59(0.02%)

ciprofol

Check the details 58(0.02%)

Case series

Check the details 58(0.02%)

repetitive transcranial magnetic stimulation

Check the details 58(0.02%)

Repetitive Transcranial Magnetic Stimulation

Check the details 55(0.02%)

Conventional Care

Check the details 53(0.02%)

Standard care

Check the details 52(0.02%)

Drug

Check the details 52(0.02%)

control group

Check the details 51(0.02%)

Maltodextrin

Check the details 51(0.02%)

exercise

Check the details 50(0.02%)

operation

Check the details 50(0.02%)

routine rehabilitation

Check the details 49(0.02%)

moxibustion

Check the details 47(0.02%)

Drug Therapy

Check the details 46(0.02%)

treatment as usual

Check the details 45(0.02%)

TACE

Check the details 45(0.02%)

Tai Chi

Check the details 45(0.02%)

conventional rehabilitation

Check the details 45(0.02%)

conventional nursing

Check the details 45(0.02%)

transcranial magnetic stimulation

Check the details 43(0.02%)

Conventional rehabilitation

Check the details 43(0.02%)

stellate ganglion block

Check the details 42(0.02%)

Routine rehabilitation training

Check the details 42(0.02%)

fecal microbiota transplantation

Check the details 41(0.02%)

N

Check the details 41(0.02%)

remifentanil

Check the details 41(0.02%)

无

Check the details 40(0.02%)

Routine management

Check the details 40(0.02%)

Routine rehabilitation training

Check the details 40(0.02%)

sham rTMS

Check the details 39(0.02%)

remazolam

Check the details 39(0.02%)

medicine

Check the details 39(0.02%)

Surgical treatment

Check the details 38(0.01%)

tDCS

Check the details 37(0.01%)

anlotinib

Check the details 37(0.01%)

Routine rehabilitation

Check the details 36(0.01%)

midazolam

Check the details 36(0.01%)

Baduanjin

Check the details 35(0.01%)

without intervention

Check the details 35(0.01%)

Laparoscopic surgery

Check the details 35(0.01%)

Routine nursing care

Check the details 35(0.01%)

Lidocaine

Check the details 35(0.01%)
欢迎访问WHO国际临床试验注册平台 Clinical Trials Hong Kong

Chinese Clinical Trial Registry, Primary Registry of WHO International Clinical Trials Registry Platform

Copyright(c) (2005 - 2023) Chictr.org.cn.All rights reserved. Chinese Clinical Trial Registry

蜀ICP备16010396号-9

Note: It is recommended to use the widescreen display resolution of Internet Explorer 8.0 or later